Drugs that contain Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate
1. Moviprep patents expiration
MOVIPREP's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7658914 | SALIX PHARMS | Colon cleansing compositions |
Sep, 2024
(4 months from now) | |
| US7169381 | SALIX PHARMS | Colon cleansing compositions and methods |
Sep, 2024
(4 months from now) | |
Market Authorisation Date: 02 August, 2006
Treatment: NA
Dosage: FOR SOLUTION;ORAL
How can I launch a generic of MOVIPREP before it's drug patent expiration?
More Information on Dosage
MOVIPREP family patents
2. Plenvu patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10780112 | SALIX | Colonoscopy-preparation |
Mar, 2032
(7 years from now) | |
| US11529368 | SALIX | Colonoscopy—preparation |
Mar, 2032
(7 years from now) | |
| US10792306 | SALIX | Colonoscopy—preparation |
Mar, 2032
(7 years from now) | |
| US10646512 | SALIX | Colonoscopy - preparation |
Mar, 2032
(7 years from now) | |
| US9592252 | SALIX | Colonoscopy—preparation |
Aug, 2032
(8 years from now) | |
| US10016504 | SALIX | Compositions |
Sep, 2033
(9 years from now) | |
| US8999313 | SALIX | Compositions |
Sep, 2033
(9 years from now) | |
| US9326969 | SALIX | Compositions |
Sep, 2033
(9 years from now) | |
| US10918723 | SALIX | Colon cleansing compositions and methods of use |
Sep, 2033
(9 years from now) | |
| US9707297 | SALIX | Compositions |
Sep, 2033
(9 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | May 04, 2021 |
Market Authorisation Date: 04 May, 2018
Treatment: For cleansing of the colon in preparation for colonoscopy in adults
Dosage: FOR SOLUTION;ORAL
How can I launch a generic of PLENVU before it's drug patent expiration?
More Information on Dosage
PLENVU family patents